CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that Thomas Hughes, Ph.D., president and chief executive officer and Maria Rupnick, M.D., Zafgen co-founder, cardiologist at Brigham and Women’s Hospital and instructor of medicine at Harvard Medical School, will present a case study of the unique anti-obesity approach and virtual business model employed at Zafgen at the upcoming Xconomy Forum: Tomorrow’s Biotech – Innovators and Innovations. Zafgen’s presentation will take place on Thursday, April 30, 2009 at 2:20 p.m. (EDT) at the Biogen Idec corporate headquarters in Cambridge, MA.
